As of 2026-10-13, the Fair Value of Moderna Inc (MRNA) is -198.53 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 213.74 USD, the upside of Moderna Inc is -192.88%.
With the market price of 213.74 USD and our fair value calculation, Moderna Inc (MRNA) is not a good investment. Investing in MRNA stocks now will result in a potential loss of 192.88%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | 12,202.00 | 8,362.00 | -4,714.00 | -3,561.00 | -2,822.00 | 1,893.40 |
| YoY growth | 1,733.47% | -31.47% | -156.37% | 24.46% | 20.75% | 318.17% |
| Market Cap (mil) | 84,809.90 |
| P/E | |
| Forward P/E |
| EPS | -7.94 |
| Avg earnings growth rate | 318.17% |
| TTM earnings | -3,151.00 |